DescriptionSizeFormat
Publisher version (open access)186 KBAdobe Acrobat PDFView/Open

Please use this identifier to cite or link to this item: http://hdl.handle.net/1959.13/27678

Title
Effects of folylpolyglutamate synthetase modulation on chemosensitivity of colon cancer cells to 5-fluorouracil and methotrexate
Author/Creator
Sohn, K.-J.;  Smirnakis, F.;  Moskovitz, D. N.;  Novakovic, P.;  Yates, Z.;  Lucock, M.;  Croxford, R.;  Kim, Y.-I.
Description
Background: Folylpoly-γ-glutamate synthetase (FPGS) converts intracellular folates and antifolates (for example, methotrexate (MTX)) to polyglutamates. Polyglutamylated folates and antifolates are retained in cells longer and are better substrates than their monoglutamate counterparts for enzymes involved in one carbon transfer. Polyglutamylation of intracellular 5,10-methylenetetrahydrofolate may also enhance the cytotoxicity of 5-fluorouracil (5-FU) by allowing more efficient formation and stabilisation of the inhibitory ternary complex involving thymidylate synthase and a 5-FU metabolite. Aim: We investigated the effects of FPGS modulation on the chemosensitivity of colon cancer cells to 5-FU and MTX. Methods: Human HCT116 colon cancer cells were stably transfected with the sense or antisense FPGS cDNA or blank (control). FPGS protein expression and enzyme activity, growth rate, intracellular folate content and composition, and in vitro chemosensitivity to 5-FU and MTX were determined. Results: Compared with cells expressing endogenous FPGS, those overexpressing FPGS had significantly faster growth rates and higher concentrations of total folate and long chain folate polyglutamates while antisense FPGS inhibition produced opposite results. FPGS overexpression significantly enhanced, whereas FPGS inhibition decreased, chemosensitivity to 5-FU. No significant difference in chemosensitivity to MTX was observed. Conclusions: These data provide functional evidence that FPGS overexpression and inhibition modulate chemosensitivity of colon cancer cells to 5-FU by altering intracellular folate polyglutamylation, providing proof of principle. Thus FPGS status may be an important predictor of chemosensitivity of colon cancer cells to 5-FU based chemotherapy, and FPGS gene transfer may increase the sensitivity of colon cancer cells to 5-FU-based chemotherapy.
Relation
Gut: an International Journal of Gastroenterology & Hepatology Vol. 53, Issue 12, p. 1825-1831
Publisher Link
http://dx.doi.org/10.1136/gut.2004.042713
Date
2004
Publisher
BMJ Publishing Group
Keyword(s)
folylpolyglutamate synthetase;  colon cancer;  chemotherapy;  5-fluorouracil;  methotrexate
Resource Type
journal article
Identifier
http://hdl.handle.net/1959.13/27678
Identifier
ISSN:0017-5749
Reviewed
Reviewed
Full Text
Full Text
 
Image Thumbnail
17 Visitors 19 Hits 0 Downloads
Save/E-mail Citation
Citation Format
E-mail Address
Subject
"Gut: an International Journal of Gastroenterology & Hepatology"
 
OR